In contrast, while separating neoplasms with diffuse immunoreactivity from neoplasms with focal positivity, Yen et al. observed that diffuse MSLN expression was correlated with the prolonged survival of HSOC patients [39]. The gene discussed is MSLN; the disease is neoplasm.